
Keywords: CT; computed tomography; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; EQ-5D; EuroQol five-dimension questionnaire; EYLL; expected years of life lost; GDP; gross domestic product; ICER; incremental cost-effectiveness ratio; NCKUH